OncologyPipelineDirector

**Uniting science, technology and talent to get ahead of disease together** GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. ​ We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas – respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. ​ ​ People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can perform and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people. GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on people’s health. ​ Our strategy is to prevent and treat disease with specialty medicines, vaccines and general medicines. ​​ We combine the science of the immune system with advanced technologies, enhanced by targeted business development and world-class partnerships, to develop new medicines and vaccines that can help transform people’s lives. **Position Summary** The Oncology Pipeline Director is responsible for representing the Canadian commercial perspective across the lifecycle of key novel oncology assets or indications including ensuring development, commercialization strategy, and launch planning are optimized for the Canadian market. This role serves as the primary Canadian commercial leader interfacing with the